Company Filing History:
Years Active: 2011
Title: **Luis A Pardo: Innovator in Antibody Technology**
Introduction
Luis A Pardo is a distinguished inventor based in Göttingen, Germany, known for his impactful contributions to the field of antibody technology. With a focus on the mammalian EAG1 ion channel protein, Pardo has developed a unique solution through his innovative work.
Latest Patents
Pardo holds a patent for "Antibodies directed to the mammalian EAG1 ion channel protein". This invention relates to a beneficial antibody, antibody fragment, or derivative that binds specifically to at least one epitope within the extracellular or intracellular domain of the EAG1 ion channel. The patent also encompasses nucleic acid molecules that encode these anti-EAG1 antibodies, as well as vectors containing such nucleic acid. Furthermore, it presents methods for preparing these antibodies and their applications for diagnosing diseases, treating conditions, detecting EAG1-expressing cells, and inhibiting EAG1 function.
Career Highlights
Luis A Pardo is affiliated with the Max Planck Society for the Advancement of Science, where his research and innovations are recognized for their significance in scientific advancement. His patent demonstrates both his commitment to innovative research and his expertise in biochemistry and molecular biology.
Collaborations
Throughout his career, Pardo has collaborated with notable researchers, including Walter Stühmer and Hendrik Knötgen. These collaborations have enhanced the depth of his research and contributed to advancements in the understanding of ion channel proteins.
Conclusion
Luis A Pardo’s contributions to biomedical research, particularly through his patent on antibodies related to the EAG1 ion channel, underscore his role as an influential inventor. His work not only pushes the boundaries of scientific knowledge but also opens new avenues for diagnosing and treating various diseases. As a prominent figure in his field, Pardo continues to inspire innovation and collaboration in the scientific community.